Reduced basal ganglia μ-opioid receptor availability in trigeminal neuropathic pain: A pilot study
<p>Abstract</p> <p>Background</p> <p>Although neuroimaging techniques have provided insights into the function of brain regions involved in Trigeminal Neuropathic Pain (TNP) in humans, there is little understanding of the molecular mechanisms affected during the course...
Main Authors: | DosSantos Marcos, Martikainen Ilkka, Nascimento Thiago, Love Tiffany M, Deboer Misty, Maslowski Eric C, Monteiro André, Vincent Maurice, Zubieta Jon-Kar, DaSilva Alexandre F |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2012-09-01
|
Series: | Molecular Pain |
Subjects: | |
Online Access: | http://www.molecularpain.com/content/8/1/74 |
Similar Items
-
Immediate effects of tDCS on the µ-opioid system of a chronic pain patient
by: Marcos Fabio DosSantos, et al.
Published: (2012-11-01) -
Non-invasive trial testing for trigeminal branch stimulation to treat refractory trigeminal neuropathic pain: A technical note
by: Georgios A. Maragkos, et al.
Published: (2020-09-01) -
Pathological Mechanisms and Therapeutic Targets for Trigeminal Neuropathic Pain
by: Pawan Bista, et al.
Published: (2019-08-01) -
Pathophysiology of Post-Traumatic Trigeminal Neuropathic Pain
by: Olga A. Korczeniewska, et al.
Published: (2022-11-01) -
Peripherally Administered Botulinum Toxin Type A Localizes Bilaterally in Trigeminal Ganglia of Animal Model
by: Arief Waskitho, et al.
Published: (2021-10-01)